K. Hartmann

发表

Safe vaccination of children with a virosomal adjuvanted influenza vaccine.

Valérie Künzi, Martin Dornseiff, Jörg Horwath, 2009, Vaccine.

Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers’ from emerging countries

S. Pagliusi, K. Hartmann, A. Precioso, 2020, Vaccine.

Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem® demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine

K. Hartmann, P. Bedford, S. Aspinall, 2012, Human vaccines & immunotherapeutics.

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.

R. Steele, J. Sejvar, J. Galama, 2007, Vaccine.

First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.

S. Kostense, C. Rupprecht, G. Weverling, 2008, Vaccine.

Real-life versus package insert: a post-marketing study on adverse-event rates of the virosomal hepatitis A vaccine Epaxal® in healthy travellers.

B. Genton, C. Herzog, R. Steffen, 2011, Vaccine.

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.

J. Sejvar, V. Wong, J. Galama, 2017, Vaccine.

Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.

C. Herzog, R. Glück, R. Mischler, 2009, Vaccine.

All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization.

V. Wong, T. Linder, J. Oleske, 2007, Vaccine.

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.

C. Herzog, J. Goudsmit, R. Kompier, 2009, Vaccine.

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons

E. Marchetti, M. Préziosi, F. Laforce, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial

J. Jimeno, X. Sáez-Llorens, J. Cramer, 2020, Vaccine.